154 related articles for article (PubMed ID: 35142058)
1. Serum IL-35 levels is a new candidate biomarker of cancer-related cachexia in stage IV non-small cell lung cancer.
Li Z; Zhu L; Zheng H; Jiang W; Wang Y; Jiang Z; Xu J
Thorac Cancer; 2022 Mar; 13(5):716-723. PubMed ID: 35142058
[TBL] [Abstract][Full Text] [Related]
2. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
3. Consequences of Late-Stage Non-Small-Cell Lung Cancer Cachexia on Muscle Metabolic Processes.
Murton AJ; Maddocks M; Stephens FB; Marimuthu K; England R; Wilcock A
Clin Lung Cancer; 2017 Jan; 18(1):e1-e11. PubMed ID: 27461772
[TBL] [Abstract][Full Text] [Related]
4. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the relationship between serum ghrelin levels and cancer cachexia in patients with locally advanced nonsmall-cell lung cancer treated with chemoradiotherapy.
Uysal P; Afsar CU; Sozer V; Inanc B; Agaoglu F; Gural Z; Fazlıoglu NY; Cuhadaroglu C; Uzun H
J Cancer Res Ther; 2020; 16(4):855-859. PubMed ID: 32930130
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab, a proposed therapy for the cachexia of Interleukin6-expressing lung cancer.
Ando K; Takahashi F; Kato M; Kaneko N; Doi T; Ohe Y; Koizumi F; Nishio K; Takahashi K
PLoS One; 2014; 9(7):e102436. PubMed ID: 25010770
[TBL] [Abstract][Full Text] [Related]
9. Blockade of the IL-6 trans-signalling/STAT3 axis suppresses cachexia in Kras-induced lung adenocarcinoma.
Miller A; McLeod L; Alhayyani S; Szczepny A; Watkins DN; Chen W; Enriori P; Ferlin W; Ruwanpura S; Jenkins BJ
Oncogene; 2017 May; 36(21):3059-3066. PubMed ID: 27893707
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
[TBL] [Abstract][Full Text] [Related]
11. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
[TBL] [Abstract][Full Text] [Related]
12. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
[TBL] [Abstract][Full Text] [Related]
14. Lung cancer-derived extracellular vesicles induced myotube atrophy and adipocyte lipolysis via the extracellular IL-6-mediated STAT3 pathway.
Hu W; Ru Z; Zhou Y; Xiao W; Sun R; Zhang S; Gao Y; Li X; Zhang X; Yang H
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Aug; 1864(8):1091-1102. PubMed ID: 31002945
[TBL] [Abstract][Full Text] [Related]
15. Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.
Antoun S; Morel H; Souquet PJ; Surmont V; Planchard D; Bonnetain F; Foucher P; Egenod T; Krakowski I; Gaudin H; Debieuvre D
J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):782-793. PubMed ID: 30932365
[TBL] [Abstract][Full Text] [Related]
16. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate prevents skeletal muscle loss in mice with lung cancer.
Goncalves MD; Hwang SK; Pauli C; Murphy CJ; Cheng Z; Hopkins BD; Wu D; Loughran RM; Emerling BM; Zhang G; Fearon DT; Cantley LC
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E743-E752. PubMed ID: 29311302
[TBL] [Abstract][Full Text] [Related]
18. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
[TBL] [Abstract][Full Text] [Related]
19. Anti-cachectic effect of clarithromycin for patients with unresectable non-small cell lung cancer.
Sakamoto M; Mikasa K; Majima T; Hamada K; Konishi M; Maeda K; Kita E; Narita N
Chemotherapy; 2001 Dec; 47(6):444-51. PubMed ID: 11786660
[TBL] [Abstract][Full Text] [Related]
20. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]